Marco Ruella

51PUBLICATIONS

338CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersHaematological tumoursMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (51)

Sort by Publication Date:

|May 15, 2026

Naïve CD4<sup>+</sup> T-cells and disease status at CART infusion correlate with clinical outcomes in real-world large B-cell lymphoma patients receiving second-line CAR T therapy.

|Apr 29, 2026

Spatial atlas of diabetic kidney disease reveals a B cell-rich subgroup.

|Mar 10, 2026

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Gregory M Chen, Ankita Jain, David T Gering

|Feb 06, 2026

The ancestral haplotype of P2RX5 yields a B-cell surface marker and a multi-lineage immunotherapy target.

Zhiwei Ang, Annette Castro, Luca Paruzzo

|Feb 04, 2026

Chimeric antigen receptor T cells against the IGHV4-34 B cell receptor specifically eliminate neoplastic and autoimmune B cells.

Ivan J Cohen, Audrey C Bochi-Layec, Jean Lemoine

|Jan 15, 2026

CD4<sup>+</sup> T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy.

Matthew Ho, Luca Paruzzo, Julia Han Noll

Pageof 9

Frequent Collaborators

16 joint publications

Luca Paruzzo

12 joint publications

Carl H June

11 joint publications

Stephen J Schuster

Joseph A Fraietta

Raymone Pajarillo

Patrizia Porazzi

Elise A Chong

Alfred L Garfall

Adam D Cohen

Bruce L Levine

Frequent Collaborators

16 joint publications

Luca Paruzzo

12 joint publications

Carl H June

11 joint publications

Stephen J Schuster

8 joint publications

Joseph A Fraietta